According to this latest study, the 2020 growth of Equine Pharmaceuticals and Supplements will have significant change from previous year. By the most conservative estimates of global Equine Pharmaceuticals and Supplements market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1095.3 million in 2019. Over the next five years the Equine Pharmaceuticals and Supplements market will register a 4.7% CAGR in terms of revenue, the global market size will reach US$ 1314.6 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Pharmaceuticals and Supplements market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Pharmaceuticals
Supplements
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Thoroughbred Horse
Other Types of Horses
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Consumption 2016-2026
2.1.2 Equine Pharmaceuticals and Supplements Consumption CAGR by Region
2.2 Equine Pharmaceuticals and Supplements Segment by Type
2.2.1 Pharmaceuticals
2.2.2 Supplements
2.3 Equine Pharmaceuticals and Supplements Sales by Type
2.3.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2021)
2.3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2016-2021)
2.3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Type (2016-2021)
2.4 Equine Pharmaceuticals and Supplements Segment by Application
2.4.1 Thoroughbred Horse
2.4.2 Other Types of Horses
2.5 Equine Pharmaceuticals and Supplements Sales by Application
2.5.1 Global Equine Pharmaceuticals and Supplements Sale Market Share by Application (2016-2021)
2.5.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Application (2016-2021)
2.5.3 Global Equine Pharmaceuticals and Supplements Sale Price by Application (2016-2021)
3 Global Equine Pharmaceuticals and Supplements by Company
3.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Company
3.1.1 Global Equine Pharmaceuticals and Supplements Sales by Company (2019-2021)
3.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2019-2021)
3.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company
3.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Company (2019-2021)
3.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2019-2021)
3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Company
3.4 Global Manufacturers Equine Pharmaceuticals and Supplements Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Pharmaceuticals and Supplements Product Location Distribution
3.4.2 Players Equine Pharmaceuticals and Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Equine Pharmaceuticals and Supplements by Region
4.1 Global Equine Pharmaceuticals and Supplements by Region
4.1.1 Global Equine Pharmaceuticals and Supplements Sales by Region
4.1.2 Global Equine Pharmaceuticals and Supplements Revenue by Region
4.2 Americas Equine Pharmaceuticals and Supplements Sales Growth
4.3 APAC Equine Pharmaceuticals and Supplements Sales Growth
4.4 Europe Equine Pharmaceuticals and Supplements Sales Growth
4.5 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Growth
5 Americas
5.1 Americas Equine Pharmaceuticals and Supplements Sales by Country
5.1.1 Americas Equine Pharmaceuticals and Supplements Sales by Country (2016-2021)
5.1.2 Americas Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021)
5.2 Americas Equine Pharmaceuticals and Supplements Sales by Type
5.3 Americas Equine Pharmaceuticals and Supplements Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Pharmaceuticals and Supplements Sales by Region
6.1.1 APAC Equine Pharmaceuticals and Supplements Sales by Region (2016-2021)
6.1.2 APAC Equine Pharmaceuticals and Supplements Revenue by Region (2016-2021)
6.2 APAC Equine Pharmaceuticals and Supplements Sales by Type
6.3 APAC Equine Pharmaceuticals and Supplements Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Equine Pharmaceuticals and Supplements by Country
7.1.1 Europe Equine Pharmaceuticals and Supplements Sales by Country (2016-2021)
7.1.2 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021)
7.2 Europe Equine Pharmaceuticals and Supplements Sales by Type
7.3 Europe Equine Pharmaceuticals and Supplements Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Equine Pharmaceuticals and Supplements by Country
8.1.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2016-2021)
8.1.2 Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021)
8.2 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type
8.3 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Equine Pharmaceuticals and Supplements Distributors
10.3 Equine Pharmaceuticals and Supplements Customer
11 Global Equine Pharmaceuticals and Supplements Market Forecast
11.1 Global Equine Pharmaceuticals and Supplements Forecast by Region
11.1.1 Global Equine Pharmaceuticals and Supplements Forecast by Regions (2021-2026)
11.2.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Equine Pharmaceuticals and Supplements Forecast by Type
11.7 Global Equine Pharmaceuticals and Supplements Forecast by Application
12 Key Players Analysis
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Boehringer Ingelheim Company Information
12.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Offered
12.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Boehringer Ingelheim Main Business Overview
12.1.5 Boehringer Ingelheim Latest Developments
12.2 Merck Animal Health
12.2.1 Merck Animal Health Company Information
12.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Offered
12.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Animal Health Main Business Overview
12.2.5 Merck Animal Health Latest Developments
12.3 Zoetis
12.3.1 Zoetis Company Information
12.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Offered
12.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Zoetis Main Business Overview
12.3.5 Zoetis Latest Developments
12.4 Bayer Animal Health
12.4.1 Bayer Animal Health Company Information
12.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Offered
12.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Bayer Animal Health Main Business Overview
12.4.5 Bayer Animal Health Latest Developments
12.5 Elanco Animal Health
12.5.1 Elanco Animal Health Company Information
12.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Offered
12.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Elanco Animal Health Main Business Overview
12.5.5 Elanco Animal Health Latest Developments
12.6 Dechra Veterinary Products
12.6.1 Dechra Veterinary Products Company Information
12.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Offered
12.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Dechra Veterinary Products Main Business Overview
12.6.5 Dechra Veterinary Products Latest Developments
12.7 CEVA
12.7.1 CEVA Company Information
12.7.2 CEVA Equine Pharmaceuticals and Supplements Product Offered
12.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 CEVA Main Business Overview
12.7.5 CEVA Latest Developments
12.8 Virbac
12.8.1 Virbac Company Information
12.8.2 Virbac Equine Pharmaceuticals and Supplements Product Offered
12.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Virbac Main Business Overview
12.8.5 Virbac Latest Developments
12.9 Norbrook Equine
12.9.1 Norbrook Equine Company Information
12.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Offered
12.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Norbrook Equine Main Business Overview
12.9.5 Norbrook Equine Latest Developments
12.10 Kyoritsu Seiyaku
12.10.1 Kyoritsu Seiyaku Company Information
12.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Offered
12.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Kyoritsu Seiyaku Main Business Overview
12.10.5 Kyoritsu Seiyaku Latest Developments
12.11 Vetoquinol
12.11.1 Vetoquinol Company Information
12.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Offered
12.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Vetoquinol Main Business Overview
12.11.5 Vetoquinol Latest Developments
12.12 Protexin Healthcare
12.12.1 Protexin Healthcare Company Information
12.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Offered
12.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Protexin Healthcare Main Business Overview
12.12.5 Protexin Healthcare Latest Developments
12.13 Audevard
12.13.1 Audevard Company Information
12.13.2 Audevard Equine Pharmaceuticals and Supplements Product Offered
12.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Audevard Main Business Overview
12.13.5 Audevard Latest Developments
12.14 Ouro Fino Saude
12.14.1 Ouro Fino Saude Company Information
12.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Offered
12.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Ouro Fino Saude Main Business Overview
12.14.5 Ouro Fino Saude Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Equine Pharmaceuticals and Supplements Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Pharmaceuticals
Table 3. Major Players of Supplements
Table 4. Global Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
Table 5. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2021)
Table 6. Global Equine Pharmaceuticals and Supplements Revenue by Type (2016-2021) & ($ million)
Table 7. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2021)
Table 8. Global Equine Pharmaceuticals and Supplements Sale Price by Type (2016-2021)
Table 9. Global Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
Table 10. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2021)
Table 11. Global Equine Pharmaceuticals and Supplements Value by Application (2016-2021)
Table 12. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2021)
Table 13. Global Equine Pharmaceuticals and Supplements Sale Price by Application (2016-2021)
Table 14. Global Equine Pharmaceuticals and Supplements Sales by Company (2019-2021) & (K Units)
Table 15. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2019-2021)
Table 16. Global Equine Pharmaceuticals and Supplements Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2019-2021)
Table 18. Global Equine Pharmaceuticals and Supplements Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Equine Pharmaceuticals and Supplements Producing Area Distribution and Sales Area
Table 20. Players Equine Pharmaceuticals and Supplements Products Offered
Table 21. Equine Pharmaceuticals and Supplements Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Equine Pharmaceuticals and Supplements Sales by Region (2016-2021) (K Units)
Table 25. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2021)
Table 26. Global Equine Pharmaceuticals and Supplements Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2016-2021)
Table 28. Americas Equine Pharmaceuticals and Supplements Sales by Country (2016-2021) & (K Units)
Table 29. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2021)
Table 30. Americas Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2021)
Table 32. Americas Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
Table 33. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2021)
Table 34. Americas Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
Table 35. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2021)
Table 36. APAC Equine Pharmaceuticals and Supplements Sales by Region (2016-2021) & (K Units)
Table 37. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2021)
Table 38. APAC Equine Pharmaceuticals and Supplements Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2016-2021)
Table 40. APAC Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
Table 41. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2021)
Table 42. APAC Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
Table 43. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2021)
Table 44. Europe Equine Pharmaceuticals and Supplements Sales by Country (2016-2021) & (K Units)
Table 45. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2021)
Table 46. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2021)
Table 48. Europe Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
Table 49. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2021)
Table 50. Europe Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
Table 51. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2021)
Table 60. Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2021-2026) & (K Units)
Table 61. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2021-2026) & (K Units)
Table 65. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Application (2021-2026)
Table 68. Boehringer Ingelheim Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 69. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Offered
Table 70. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 71. Boehringer Ingelheim Main Business
Table 72. Boehringer Ingelheim Latest Developments
Table 73. Merck Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Animal Health Equine Pharmaceuticals and Supplements Product Offered
Table 75. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 76. Merck Animal Health Main Business
Table 77. Merck Animal Health Latest Developments
Table 78. Zoetis Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Equine Pharmaceuticals and Supplements Product Offered
Table 80. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Bayer Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Offered
Table 85. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 86. Bayer Animal Health Main Business
Table 87. Bayer Animal Health Latest Developments
Table 88. Elanco Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 89. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Offered
Table 90. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Elanco Animal Health Main Business
Table 92. Elanco Animal Health Latest Developments
Table 93. Dechra Veterinary Products Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 94. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Offered
Table 95. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Dechra Veterinary Products Main Business
Table 97. Dechra Veterinary Products Latest Developments
Table 98. CEVA Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 99. CEVA Equine Pharmaceuticals and Supplements Product Offered
Table 100. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. CEVA Main Business
Table 102. CEVA Latest Developments
Table 103. Virbac Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 104. Virbac Equine Pharmaceuticals and Supplements Product Offered
Table 105. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Virbac Main Business
Table 107. Virbac Latest Developments
Table 108. Norbrook Equine Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 109. Norbrook Equine Equine Pharmaceuticals and Supplements Product Offered
Table 110. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. Norbrook Equine Main Business
Table 112. Norbrook Equine Latest Developments
Table 113. Kyoritsu Seiyaku Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 114. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Offered
Table 115. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. Kyoritsu Seiyaku Main Business
Table 117. Kyoritsu Seiyaku Latest Developments
Table 118. Vetoquinol Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 119. Vetoquinol Equine Pharmaceuticals and Supplements Product Offered
Table 120. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. Vetoquinol Main Business
Table 122. Vetoquinol Latest Developments
Table 123. Protexin Healthcare Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 124. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Offered
Table 125. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. Protexin Healthcare Main Business
Table 127. Protexin Healthcare Latest Developments
Table 128. Audevard Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 129. Audevard Equine Pharmaceuticals and Supplements Product Offered
Table 130. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 131. Audevard Main Business
Table 132. Audevard Latest Developments
Table 133. Ouro Fino Saude Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 134. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Offered
Table 135. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 136. Ouro Fino Saude Main Business
Table 137. Ouro Fino Saude Latest Developments
List of Figures
Figure 1. Picture of Equine Pharmaceuticals and Supplements
Figure 2. Equine Pharmaceuticals and Supplements Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Pharmaceuticals and Supplements Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Equine Pharmaceuticals and Supplements Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Equine Pharmaceuticals and Supplements Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Pharmaceuticals
Figure 10. Product Picture of Supplements
Figure 11. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2020
Figure 12. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2021)
Figure 13. Equine Pharmaceuticals and Supplements Consumed in Thoroughbred Horse
Figure 14. Global Equine Pharmaceuticals and Supplements Market: Thoroughbred Horse (2016-2021) & (K Units)
Figure 15. Equine Pharmaceuticals and Supplements Consumed in Other Types of Horses
Figure 16. Global Equine Pharmaceuticals and Supplements Market: Other Types of Horses (2016-2021) & (K Units)
Figure 17. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2021)
Figure 18. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application in 2020
Figure 19. Global Equine Pharmaceuticals and Supplements Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company in 2020
Figure 21. Global Equine Pharmaceuticals and Supplements Sales Market Share by Regions (2016-2021)
Figure 22. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region in 2020
Figure 23. Americas Equine Pharmaceuticals and Supplements Sales 2016-2021 (K Units)
Figure 24. Americas Equine Pharmaceuticals and Supplements Revenue 2016-2021 ($ Millions)
Figure 25. APAC Equine Pharmaceuticals and Supplements Sales 2016-2021 (K Units)
Figure 26. APAC Equine Pharmaceuticals and Supplements Revenue 2016-2021 ($ Millions)
Figure 27. Europe Equine Pharmaceuticals and Supplements Sales 2016-2021 (K Units)
Figure 28. Europe Equine Pharmaceuticals and Supplements Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Equine Pharmaceuticals and Supplements Sales 2016-2021 (K Units)
Figure 30. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue 2016-2021 ($ Millions)
Figure 31. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2020
Figure 32. Americas Equine Pharmaceuticals and Supplements Revenue Market Share by Country in 2020
Figure 33. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2020
Figure 34. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2020
Figure 35. United States Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2020
Figure 40. APAC Equine Pharmaceuticals and Supplements Revenue Market Share by Regions in 2020
Figure 41. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2020
Figure 42. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2020
Figure 43. China Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2020
Figure 50. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country in 2020
Figure 51. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2020
Figure 52. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2020
Figure 53. Germany Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2020
Figure 62. Egypt Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Equine Pharmaceuticals and Supplements Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles